Active Not Recruiting OBSERVATIONAL NCT06444152

Prevalence of Epstein-Barr Virus Infection

Prevalence of Epstein-Barr Virus Infection in HIV Infected and HIV Uninfected Patients Presenting With Lymphomas in Botswana

Sponsor: University of Botswana

Conditions Lymph Node Excision Biopsy

Interventions Sample analysis

Updated 4 times since 2024 Last updated: Jan 28, 2026 Started: Aug 1, 2023 Primary completion: Dec 20, 2027 Completion: Dec 20, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06444152, this observational or N/A phase trial focuses on Lymph Node Excision Biopsy and remains ongoing. Sponsored by University of Botswana, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Active Not Recruiting
Feb 2025 — Feb 2026 [monthly]

Active Not Recruiting
Sep 2024 — Feb 2025 [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting

First recorded

Aug 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Botswana
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gaborone, Botswana